- Home
- ORI vs PEN Comparison
ORI vs PEN Comparison
Compare ORI & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORI
- PEN
- Stock Information
- Founded
- ORI 1923
- PEN 2004
- Country
- ORI United States
- PEN United States
- Employees
- ORI N/A
- PEN N/A
- Industry
- ORI Property-Casualty Insurers
- PEN Medical/Dental Instruments
- Sector
- ORI Finance
- PEN Health Care
- Exchange
- ORI Nasdaq
- PEN Nasdaq
- Market Cap
- ORI 9.4B
- PEN 10.1B
- IPO Year
- ORI N/A
- PEN 2015
- Fundamental
- Price
- ORI $36.59
- PEN $238.44
- Analyst Decision
- ORI Buy
- PEN Strong Buy
- Analyst Count
- ORI 1
- PEN 16
- Target Price
- ORI $43.00
- PEN $302.40
- AVG Volume (30 Days)
- ORI 1.5M
- PEN 404.1K
- Earning Date
- ORI 07-24-2025
- PEN 07-29-2025
- Dividend Yield
- ORI 3.16%
- PEN N/A
- EPS Growth
- ORI 19.19
- PEN N/A
- EPS
- ORI 3.04
- PEN 1.08
- Revenue
- ORI $8,329,500,000.00
- PEN $1,240,100,000.00
- Revenue This Year
- ORI $8.35
- PEN $14.60
- Revenue Next Year
- ORI $6.23
- PEN $14.24
- P/E Ratio
- ORI $12.06
- PEN $221.29
- Revenue Growth
- ORI 10.83
- PEN 13.17
- 52 Week Low
- ORI $30.61
- PEN $148.00
- 52 Week High
- ORI $39.84
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- ORI 40.02
- PEN 26.12
- Support Level
- ORI $36.19
- PEN $240.12
- Resistance Level
- ORI $38.20
- PEN $253.94
- Average True Range (ATR)
- ORI 0.67
- PEN 5.78
- MACD
- ORI -0.12
- PEN -0.66
- Stochastic Oscillator
- ORI 16.60
- PEN 10.05
About ORI Old Republic International Corporation
Old Republic International Corp offers a diverse range of specialized insurance products to individuals and institutions. The company operates in two segments: Specialty Insurance and Title Insurance. The Insurances provided by the company includes Automobile Extended Warranty Insurance, Aviation, Commercial Automobile Insurance, Inland Marine, Travel Accident, Workers' Compensation, Financial Indemnity, and others.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.